TipRanks
Prescient Therapeutics Limited (AU:PTX)
ASX:PTX
Australian Market
PTX
Prescient Therapeutics Limited
RESEARCH TOOLSreports
Want to see AU:PTX full AI Analyst Report?

Prescient Therapeutics Limited (PTX) Income Statement

24 Followers

Prescient Therapeutics Limited Income Statement

Last quarter (Q4 2026), Prescient Therapeutics Limited's total revenue was AU$0.00, a decrease of -100.00% from the same quarter last year. In Q4, Prescient Therapeutics Limited's net income was AU$-3.02M. See Prescient Therapeutics Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Jun 26Jun 25Jun 24Jun 23Jun 22
Total Revenue
AU$ 0.00AU$ 4.36MAU$ 3.71MAU$ 2.43MAU$ 1.89M
Gross Profit
AU$ -110.34KAU$ 4.36MAU$ 3.71MAU$ 2.43MAU$ 1.89M
Operating Expenses
AU$ 10.48MAU$ 11.89MAU$ 10.90MAU$ 9.88MAU$ 7.10M
Depreciation and Amortization
AU$ 110.34KAU$ 717.00AU$ 717.00AU$ 2.09KAU$ 1.40K
EBITDA
AU$ -10.48MAU$ -7.54MAU$ -7.19MAU$ -7.46MAU$ -6.86M
Operating Income
AU$ -10.59MAU$ -7.54MAU$ -7.19MAU$ -9.89MAU$ -7.10M
Other Income/Expenses
AU$ 147.23KAU$ 213.23KAU$ -4.76MAU$ 513.36KAU$ 231.08K
Pretax Income
AU$ -10.44MAU$ -7.32MAU$ -11.95MAU$ -9.37MAU$ -6.87M
Net Income
AU$ -7.00MAU$ -7.32MAU$ -8.24MAU$ -7.00MAU$ -5.12M
Per Share Metrics
Basic EPS
AU$ >-0.01AU$ >-0.01AU$ -0.01AU$ -0.01AU$ -0.01
Diluted EPS
AU$ >-0.01AU$ >-0.01AU$ -0.01AU$ -0.01AU$ -0.01
Weighted Average Shares Outstanding
 1.03B 804.76M 805.31M 727.53M 647.80M
Weighted Average Shares Outstanding (Diluted)
 1.03B 805.31M 805.31M 727.53M 647.80M
Currency in AUD

Prescient Therapeutics Limited Earnings and Revenue History